Introduction
============

Intestinal microbiota play a fundamentally important role in health and diseases (Backhed et al., [@B1]). Recently, the relationship between intestinal microbiota and systemic phenomena beyond the intestinal environment, such as obesity (Turnbaugh et al., [@B25]) and lifespan (Matsumoto et al., [@B15]), have been reported. The bidirectional signaling between the gastrointestinal tract and the brain, the gut-brain axis, is vital for maintaining homeostasis and is regulated at the neural, hormonal, and immunological levels. The importance of the gut-brain axis is further emphasized by the high incidence of co-morbidities between stress-related psychiatric disorders such as anxiety, and gastrointestinal disorders (Camara et al., [@B2]). Recent studies have investigated the effect of gut microbiota on brain and behavior. The results of these studies suggest that intestinal microbiota have a great impact on gut-brain communication, which led to the coining of the term "microbiota-gut-brain axis" (MGB axis) (Rhee et al., [@B21]; Cryan and Dinan, [@B4]). For example, intestinal microbiota modulates brain development and subsequent adult behavior, such as motor activity and anxiety (Heijtz et al., [@B9]; Neufeld et al., [@B18]). Studies on the MGB axis have focused on the central nervous system (CNS), including the hypothalamic-pituitary-adrenal axis (Sudo et al., [@B23]; Rhee et al., [@B21]), neurotransmitter, and synapse related factors (for example, PSD-95, synaptophysin; Heijtz et al., [@B9]), and brain-derived neurotrophic factor (Heijtz et al., [@B9]; Neufeld et al., [@B18]). However, to the best of our knowledge, other metabolites stimulated by the MGB axis have not been investigated. Furthermore, some metabolites may be synthesized independently in the brain and may be influenced by MGB axis, while some metabolites produced by intestinal bacteria may be transported from the colonic lumen to the brain in the bloodstream without filtration by blood-brain barrier (BBB).

Capillary electrophoresis with time-of-flight mass spectrometry (CE-TOFMS) is a novel strategy for analyzing and differentially displaying metabolic profiles (Monton and Soga, [@B17]). Here, using CE-TOFMS, we analyzed the cerebral metabolome obtained from germ-free (GF) mice and Ex-GF mice, harboring intestinal microbiota from specific pathogen-free mice and demonstrated the large effect of intestinal microbiota on the cerebral metabolome.

Materials and Methods
=====================

Mice
----

Germ-free BALB/c mice were purchased originally from Japan Clea Inc. (Tokyo, Japan), and were bred in the Department of Infectious Diseases, Tokai University School of Medicine, Kanagawa, Japan. We divided six male mice bred from mating into two groups, GF mice (GF 1--3) and Ex-GF mice (Ex-GF 1--3). Mice were housed in Trexler-Type flexible film plastic isolators with sterilized clean tip (CLEA Japan, Inc., Tokyo) as bedding. They were given sterilized water and sterilized commercial CL-2 pellets, which consisted of moisture (8.5%), crude protein (24.5%), crude fat (8.0%), crude fiber (4.4%), crude ash (8.5%), and nitrogen free extracts (48.2%), corresponding to 344.7 kcal/100 g (CLEA Japan, Inc.), *ad libitum*. The diet was sterilized with an autoclave (121°C, 30 min). Surveillance for bacterial contamination was performed by periodic bacteriological examination of feces throughout the experiments. Ex-GF mice were inoculated at 4 weeks of age into the stomach by a metal catheter with 0.5 mL of a 10^−1^ suspension of feces obtained from SPF BALB/c mice. The protocols approved by the Kyodo Milk Animal Use Committee (Permit Number: 2009-02) and all experimental procedures were performed according to the guidelines of the Animal Care Committee of Tokai University.

Specimen preparation and CE-TOFMS
---------------------------------

Mice (7-week-old mice) were sacrificed by cervical dislocation. The brain was resected on ice, and prefrontal cortex was sliced between 2.5 and 3.5 mm anterior to bregma within 5 min of sacrifice. Immediately after the sacrifaction, cardiac blood (approximately approximately 100 μl) was collected, and sodium ethylenediamine tetraacetate plasma (final concentration was 0.13%) was prepared by centrifugation for 20 min at 2,300 × *g* and 4°C. The samples were stored at −80°C until use.

Cardiac plasma (50 μl) and methanol (450 μl) with 50 μM intestinal standard were vortexed. The plasma homogenate served as crude metabolome and was added to chloroform (500 μl) and Milli-Q (200 μl), mixed, and centrifuged (2,300 × *g*, for 5 min at 4°C). The aqueous layer was centrifugally filtered through a 5-kDa cutoff filter Ultrafree-MC (Millipore). The filtrated solution was dried up and suspended in 25 μL Milli-Q water just before the measurement. The cerebrums were suspended in methanol (500 μl) with 50 μM intestinal standard and vortexed vigorously five times for 60 s with a MicroSmash MS-100R (Tomy Digital Biology Co., Ltd., Tokyo, Japan) at 4,000 rpm. The resulting cerebrum sample served as crude metabolome that subsequently underwent the same treatment as the plasma crude metabolome.

Metabolomics measurement and data processing were performed as described previously with an Agilent Capillary Electrophoresis System (Ooga et al., [@B19]). The CE-MS system is the Agilent G1600A Capillary Electrophoresis System connected with the Agilent G1969A LC/MSD TOF (Agilent Technologies, Palo Alto, CA, USA).

RNA preparation and quantitative real-time PCR of the cerebrums
---------------------------------------------------------------

Frozen prefrontal cerebrums were processed for total RNA preparation with TaKaRa FastPure RNA Kits (Takara Bio Inc., Otsu, Japan). The quantity, purity, and integrity were confirmed initially by electrophoresis. cDNA for each sample was synthesized using 200 ng total RNA and PrimeScript RT reagent Kits (Takara Bio Inc.). Real-time PCR was performed with a StepOne Real-Time PCR System (Applied Biosystems) with TaqMan Fast Universal PCR Master Mix (Applied Biosystems) using TaqMan probes (hexokinase 1: Mm00439344_m1, phosphofructokinase: Mm00445461_m1, and β-actin: Mm02619580_g1). The comparative delta *C*~t~ method was used for normalizations to the housekeeping gene β-actin.

Intestinal bacterial compositions
---------------------------------

Bacterial compositions were determined using pyrosequencing system. Bacterial DNA was isolated from colonic content samples of mice. The 16S rRNA was targeted to identify intestinal bacteria and a pair of universal primers; 27f (5 --AGA GTT TGA TCC TGG CTC AG--3) and 350r (5 --CTG CTG CCT CCC GTA G--3) were used for PCR. Amplicons were applied to GS titanium sequencing Kit (Roche Diagnostics) include emulsion PCR and analyzed by Genome sequencer FLX system (Roche Diagnostics). About 18,000--20,500 sequences in each sample were identified. Sequences data were compared with DDBJ database (Blast) and classified by taxonomic categories.

Data analysis and statistics
----------------------------

Clustering analysis in metabolome was processed by MATLAB 2008a (MathWorks, MA, USA). Differences in relative quantity between GF mice and Ex-GF mice were evaluated for individual metabolites by Welch's *t*-test.

Results
=======

The difference in cerebral metabolome between GF and Ex-GF mice
---------------------------------------------------------------

When the mice were sacrificed, the body weights of GF mice were between 22 and 24 g and those of Ex-GF mice were between 22 and 25 g. CE-TOFMS identified 196 (120 cations and 76 anions) metabolites from the cerebral metabolome in both of GF and Ex-GF mice. Hierarchical clustering of metabolite patterns is shown in Figure [1](#F1){ref-type="fig"}A. A remarkable difference was observed in the cerebral metabolome between GF and Ex-GF mice. Of the 196 metabolites in the cerebral metabolome, the concentrations of 23 metabolites were at least 1.6-fold, and/or significantly (*p* \< 0.05) higher, in GF mice than Ex-GF mice (group GF \> Ex-GF). A further 15 metabolites were at least 1.6-fold, and significantly (*p* \< 0.05) higher, in Ex-GF mice than GF mice (group GF \< Ex-GF), and/or 158 metabolites showed no difference in concentration or incidence between GF and Ex-GF mice (Figure [1](#F1){ref-type="fig"}B).

![**Difference in the cerebral metabolome between GF mice and Ex-GF mice**. **(A)** Hierarchical clustering showing patterns of metabolites. Red and green indicate high and low concentrations of metabolites, respectively. **(B)** The number of cerebral metabolites in the group. GF \> Ex-GF; GF ≈ Ex-GF; and GF \< Ex-GF.](fnsys-07-00009-g001){#F1}

Identified metabolites were classified into eight categories and are listed in Table [A1](#TA1){ref-type="table"} in Appendix (anion) and Table [A2](#TA2){ref-type="table"} (cation) in Appendix. Metabolites, in which there are significant differences between GF and Ex-GF mice, are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

**Metabolites whose concentrations were higher in the cerebral metabolome of Ex-GF mice than in that of GF mice**.

  Compound name                    Category          Mean       SD         Ratio                        
  -------------------------------- ----------------- ---------- ---------- ---------- ---------- ------ ------------
  Trimethylamine *N*-oxide         Alkylamino acid   1.87E-05   8.20E-05   3.37E-06   1.53E-05   4.39   \*
  *N*^5^-Ethylglutamine            Alkylamino acid   6.06E-05   1.43E-04   6.62E-06   2.43E-05   2.36   \*
  Cysteine glutathione disulfide   Peptide           3.12E-04   6.78E-04   2.78E-04   4.36E-04   2.17   
  2,3-Diphosphoglyceric acid                         8.67E-05   1.61E-04   2.73E-05   3.98E-05   1.85   *p* \< 0.1
  Cys                              Amino acid        8.61E-04   1.54E-03   7.09E-04   9.51E-04   1.79   
  2-Methylserine                                     4.90E-05   8.70E-05   4.25E-06   1.25E-05   1.78   \*
  3-Methylhistidine                Alkylamino acid   6.14E-04   1.03E-03   6.71E-05   1.34E-04   1.68   \*
  Cystine                          Peptide           1.96E-05   3.28E-05   NA         5.53E-06   1.67   
  Trp                              Amino acid        9.74E-04   1.44E-03   2.74E-05   1.13E-04   1.48   \*
  Pipecolic acid                                     1.61E-04   2.33E-04   7.37E-07   1.28E-05   1.44   \*
  Tyr                              Amino acid        3.47E-03   4.75E-03   3.16E-04   3.81E-04   1.37   \*
  Phe                              Amino acid        3.74E-03   4.97E-03   1.44E-04   1.38E-04   1.33   \*\*\*
  Asp                              Amino acid        2.72E-03   3.43E-03   2.78E-05   1.20E-04   1.26   \*\*
  Ribose 5-phosphate               Energy            1.11E-04   1.32E-04   3.22E-06   9.09E-06   1.19   \*
  Gln                              Amino acid        7.12E-03   8.46E-03   1.74E-04   4.57E-04   1.19   \*

*\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 (GF vs. Ex-GF)*.

*These metabolites have significant or more than 1.6-fold difference between GF mice and Ex-GF*.

###### 

**Metabolites whose concentrations were lower in the cerebral metabolome of Ex-GF mice than in that of GF mice**.

  Compound name                Category             Mean       SD         Ratio                        
  ---------------------------- -------------------- ---------- ---------- ---------- ---------- ------ ------------
  *N*-Acetylneuraminic acid    Alkylamino acid      1.03E-03   8.75E-04   4.35E-05   5.59E-05   0.85   \*
  *N*-Acetylaspartic acid      Neuron transmitter   2.06E-01   1.72E-01   1.04E-02   8.54E-03   0.84   \*
  Pantothenic acid             Co-enzyme            4.37E-04   3.58E-04   2.08E-05   3.18E-05   0.82   \*
  Biotin                       Co-enzyme            2.22E-04   1.79E-04   1.66E-05   1.83E-05   0.80   \*
  Ser                          Amino acid           1.05E-03   7.95E-04   6.49E-05   5.53E-05   0.76   \*\*
  ADP                          Nucleic acid         5.09E-03   3.85E-03   5.37E-04   1.32E-04   0.76   \*
  1-Methylnicotinamide         Alkylamino acid      5.04E-05   3.71E-05   5.17E-06   5.00E-06   0.74   \*
  Ser-Glu                      Peptide              4.69E-05   3.42E-05   5.47E-06   4.85E-06   0.73   \*
  Succinic acid                Energy               2.01E-02   1.45E-02   1.25E-03   1.68E-03   0.72   \*
  3-Phenylpropionic acid                            1.23E-04   8.80E-05   1.30E-05   9.03E-06   0.71   \*
  Dihydroxyacetone phosphate   Energy               2.02E-04   1.40E-04   1.23E-05   2.27E-05   0.69   \*
  IMP                          Nucleic acid         2.67E-03   1.84E-03   1.70E-04   2.63E-04   0.69   \*
  2-Hydroxybutyric acid                             8.39E-05   5.77E-05   8.91E-06   8.28E-06   0.69   \*
  NADP^+^                      Co-enzyme            8.69E-05   5.68E-05   3.79E-06   1.27E-05   0.65   \*
  Hydroxyproline               Amino acid           1.64E-03   1.07E-03   3.18E-05   1.14E-04   0.65   \*\*
  NADH                         Co-enzyme            2.09E-04   1.35E-04   2.26E-05   2.52E-05   0.65   \*
  3-Phosphoglyceric acid                            5.54E-04   3.44E-04   9.54E-05   2.31E-05   0.62   *p* \< 0.1
  Glycerol 3-phosphate                              3.77E-03   2.31E-03   2.93E-04   1.27E-03   0.61   
  Glucose 6-phosphate          Energy               1.01E-04   6.03E-05   2.05E-05   2.93E-06   0.60   *p* \< 0.1
  Fructose 6-phosphate         Energy               2.68E-05   1.54E-05   7.92E-06   2.03E-06   0.57   
  Dopamine                     Neuron transmitter   5.26E-04   2.85E-04   2.16E-04   5.60E-05   0.54   
  Fructose 1,6-diphosphate     Energy               5.43E-04   2.67E-04   1.52E-04   4.13E-05   0.49   *p* \< 0.1
  Taurocholic acid             Bile acid            1.51E-04   2.26E-05   3.08E-05   1.17E-05   0.15   \*\*

*\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 (GF vs. Ex-GF)*.

*These metabolites have significant or more than 1.6-fold difference between GF mice and Ex-GF*.

Influence of intestinal microbiota on cerebral glycolytic metabolism
--------------------------------------------------------------------

The relative quantities of the annotated metabolites in the principal metabolic pathways are represented as bar graphs (Figure [2](#F2){ref-type="fig"}). The concentrations of metabolites involved in glycolysis/gluconeogenesis pathways are characteristically higher in GF mice than in Ex-GF mice. Therefore, we focused our work on cerebral glycolytic metabolism (Figure [3](#F3){ref-type="fig"}A). The concentration of ADP and NADH were significantly (*p* \< 0.05) higher, while there was a tendency for concentrations of ATP, AMP, and NAD^+^ to be higher in GF mice than Ex-GF mice. The NADH/NAD^+^ ratio tended to be lower in GF mice than in Ex-GF mice (Figure [3](#F3){ref-type="fig"}B). There was no difference in the expression of the hexokinase and phosphofructokinase genes, between GF mice and Ex-GF mice (Figure [3](#F3){ref-type="fig"}C).

![**Differences of cerebral metabolites between GF mice and Ex-GF mice on the principal metabolic pathways**. The relative quantities of the annotated metabolites are represented as bar graphs (blue, GF: red, Ex-GF). Metabolites surrounded by blue and red circles are of higher and lower concentrations, respectively, in GF mice than Ex-GF mice. ND, not detected.](fnsys-07-00009-g002){#F2}

![**Comparison of glycolytic metabolic activity between GF mice and Ex-GF mice**. **(A)** The relative quantities of the annotated metabolites are represented as bar graphs (blue, GF: red, Ex-GF). **(B)** Relative quantities of ATP, ADP, AMP, and nicotinamides (\**p* \< 0.05). **(C)** Cerebral gene expression of hexokinase and phosphofructokinase. Data are represented as mean ± SD **(A,B)** and mean ± SEM **(C)**.](fnsys-07-00009-g003){#F3}

Comparison of individual differences in metabolome between colonic luminal content, cardiac plasma, and the cerebrum
--------------------------------------------------------------------------------------------------------------------

Relative standard deviations (RSD% = value of standard deviation/value of mean × 100) of metabolites in the colonic luminal content, cardiac plasma, and the cerebrum of GF and Ex-GF mice are shown in Figure [4](#F4){ref-type="fig"}. The RSD value of metabolites in the cerebrum was similar between GF and Ex-GF mice. However, in Ex-GF mice, the RSD values in cardiac plasma (*p* = 0.10) and colonic luminal content (*p* \< 0.001) were larger than in GF mice. In addition, in Ex-GF mice, the RSD values were the highest for colonic content (vs. cardiac plasma, *p* \< 0.01), followed by cardiac plasma (vs. the cerebrum, *p* \< 0.05) and the cerebrum. In contrast, in GF mice, the RSD value did not differ between colonic content and cardiac plasma, although that of cardiac plasma was greater than that of the cerebrum (*p* \< 0.05).

![**The boxplot of RSD% of all metabolites detected from colonic luminal content, cardiac plasma, and the cerebrum**. Blue cross bars represent the comparison of means between Ex-GF mice and GF mice. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 (GF vs. Ex-GF).](fnsys-07-00009-g004){#F4}

Comparisons of metabolites between colonic luminal content, cardiac plasma, and the cerebrum
--------------------------------------------------------------------------------------------

We compared the 38 metabolites, which were significantly altered between the cerebrum of GF and Ex-GF mice. The relative quantitative ratio (Ex-GF/GF value) for the expression of each metabolite in colonic luminal content, cardiac plasma, and the cerebrum are shown in Figure [5](#F5){ref-type="fig"}. Six metabolites, which are shown in red, had similar Ex-GF/GF ratios in all three sites. Although detected in the cerebrum, 12 metabolites, which are shown in blue, were below the detection limit in cardiac plasma. A total of 16 metabolites, which are marked by the "\#" symbol, had different Ex-GF/GF ratios between the cerebrum and cardiac plasma. The Ex-GF/GF ratios of all other metabolites did not differ between the three specimens.

![**Relative quantitative ratio (Ex-GF/GF value) comparisons of 38 metabolites between GF mice and Ex-GF mice, colonic luminal content, cardiac plasma, and the cerebrum**. Metabolites shown in red have similar Ex-GF/GF ratios between the colonic lumen, cardiac plasma, and the cerebrum. Metabolites shown in blue are below the detection limit in cardiac plasma, but were detected in the cerebrum. ^\#^These metabolites differed in Ex-GF/GF ratios between the cerebrum and cardiac plasma. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 (GF vs. Ex-GF). ND, not detected.](fnsys-07-00009-g005){#F5}

Intestinal bacterial compositions
---------------------------------

Bacterial compositions were analyzed using FLX systems and the results are shown in Figure [6](#F6){ref-type="fig"}. Phylum Firmicutes (80%) and phylum Bacteroidetes (about 6%) have been identified as dominant populations in all samples. Following detailed classification on the family level, the families *Lactobacillaceae*, *Lachnospiraceae*, *Clostridiaceae*, and *Bacteroidaceae* were commonly detected and constituted higher proportions in the population, i.e., 50--70, 3--10, 2--5, and 2--4% respectively, than other families. However, there were only small individual differences among the samples. These families accounted for up to 60--70% of the total bacterial population.

![**Aggregate microbiota composition at the phylum and family levels in the colonic content of Ex-GF mice**.](fnsys-07-00009-g006){#F6}

Discussion
==========

To the best of our knowledge, in a prior study by Fu et al. ([@B7]), the highest numbers of metabolites from brain tissue to date were detected using GC-MS. In total, 118 metabolites were routinely detected in more than 80% of samples in one or more of three species (human, chimpanzee, or rhesus macaques), in at least one brain region (prefrontal or cerebellar cortex). However, only 61 metabolites were annotated. CE-TOFMS identified 196 metabolites from the cerebral metabolome, indicating that CE-TOFMS is more sensitive than GC-MS for comprehensive and large-scale metabolomic analysis in the brain.

Neurotransmitters and several metabolites which are involved in brain function
------------------------------------------------------------------------------

Concentration of dopamine (DA), a target for amphetamine stimulation of locomotor activity and stereotyped behaviors, was approximately twofold higher (*p* = 0.188) in GF mice than in Ex-GF mice. This is consistent with the findings that GF mice display increased motor activity and reduced anxiety compared with their Ex-CF counterparts (Heijtz et al., [@B9]; Neufeld et al., [@B18]). It is confusing that the concentration of Tyr in the cerebrum of Ex-GF mice was higher than that of GF mice, since Tyr is a precursor of DA. Tyr hydroxylase hydroxylates Tyr to [l]{.smallcaps}-DOPA, which was below the detection limit in this study. DOPA is further converted to DA by aromatic amino acid decarboxylase (Daubner et al., [@B5]). Therefore, this indicates that cerebral DA synthesis is induced by DA-producing enzymes, which are inhibited by stimulation of intestinal microbiota through the MGB axis (Figure [7](#F7){ref-type="fig"}A). Parkinson disease is characterized by a progressive loss of dopaminergic neurons in the substantia nigra. Since the activity level of Tyr hydroxylase is associated with Parkinson disease (Haavik and Toska, [@B8]), it is possible that the intestinal microbiota is involved in the development of Parkinson disease.

![**Relative quantitative comparisons of metabolites in the biosynthetic pathway for dopamine (A) and serotonin (B), in the cerebrum of GF mice and Ex-GF mice**. Data are represented as mean ± SD. \**p* \< 0.05, \*\*\**p* \< 0.001 (GF vs. Ex-GF).](fnsys-07-00009-g007){#F7}

We were also surprised to find that the concentrations of Trp, precursors of serotonin (5-HT), in the cerebrum of Ex-GF mice were higher than that of GF mice. This was despite the fact that cerebral 5-HT concentration did not differ between GF mice and Ex-GF mice (Figure [7](#F7){ref-type="fig"}B). It is believed that brain 5-HT concentration is dependent on the brain Trp level (Fernstrom, [@B6]). Plasma Trp are transported into the brain by a transporter, located at BBB on CNS capillary endothelial cells (Pardridge, [@B20]), and converted to 5-HT in neurons containing Trp hydroxylase, the rate-limiting enzyme in 5-HT synthesis (Jequier et al., [@B11]). Therefore, we suppose that cerebral 5-HT synthesis is regulated by Trp hydroxylase in neurons without the influence of the cerebral Trp pool and/or intestinal microbiota under the non-stressed condition and in non-neonates, as in our present study.

Several metabolites, which are known to be involved in brain function, are also influenced by normal intestinal microbiota. *N*-acetylaspartic acid (NAA), which is in group GF \> Ex-GF, is an amino acid present in the vertebrate brain that is synthesized and stored primarily in neurons and considered a marker for neuronal health and attenuation (Simmons et al., [@B22]; Jenkins et al., [@B10]). Pipecolic acid, which is in the GF \< Ex-GF group, is known as a neuromodulator or neurotransmitter with the gamma-aminobutyric acid (GABA)ergic transmission. Pipecolic acid was shown to be region- and site-specific in the CNS (Kase et al., [@B12]), which causes hepatic encephalopathy by inducing neuronal cell death, or apoptosis, rather than by depressing neurotransmissions (Matsumoto et al., [@B16]). Ser was in the GF \> Ex-GF group; [d]{.smallcaps}-Ser is synthesized from [l]{.smallcaps}-Ser by serine racemase (CE-TOFMS could not separate [d]{.smallcaps}-Ser and [l]{.smallcaps}-Ser) in the human brain. It functions as an obligatory co-agonist at the glycine modulatory site of *N*-methyl-[d]{.smallcaps}-aspartate (NMDA)-selective glutamate receptors. Thus, depletion of [d]{.smallcaps}-Ser levels has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia (Yang et al., [@B27]). *N*-acetylneuraminic acid (NANA), which was in group GF \> Ex-GF, increased learning and memory performance (Wang et al., [@B26]). These findings indicate that intestinal microbiota are closely related to brain health, disease development, attenuation, learning, and memory.

Cerebral energy metabolism
--------------------------

The concentration of several cerebral glycolysis intermediates was higher in GF mice than in Ex-GF mice (Figure [3](#F3){ref-type="fig"}A). This raises the following two possibilities: first, the cerebral energy consumption of Ex-GF mice is higher than that of GF mice, and second, that cerebral energy production by glycolysis in Ex-GF mice is lower than in GF mice. However, these phenomena presumably indicate an accelerated molecular flux of the glycolysis pathway to compensate for ATP and NADH depletion in the cerebrum of Ex-GF mice. This assumption is based on our finding that the cerebral ATP (Ex-GF/GF ratio = 0.91) and NADH (Ex-GF/GF ratio = 0.65) levels were lower in Ex-GF mice than GF mice (Figure [3](#F3){ref-type="fig"}B) and there was no difference in cerebral hexokinase and phosphofructokinase gene expression between mice (Figure [3](#F3){ref-type="fig"}C). In fact, levels of acetyl CoA, which is produced by oxidation from pyruvic acid, was similar in the cerebrum of GF and Ex-GF mice. Furthermore, a significant difference in lactic acid was not observed, suggesting that the normal intestinal microbiota do not influence anaerobic respiration and the compensated molecular components (ATP or NADH) of the glycolysis pathway in Ex-GF mice was then transferred into the TCA cycle for further aerobic respiration via acetyl CoA in the cerebral mitochondria. To support the presence of an active TCA cycle, we also report changes in NADH and NAD^+^. The ratio between NADH and NAD^+^ affects mitochondrial TCA cycle activity (LaNoue et al., [@B13]). NADH and NADH/NAD^+^ ratio in Ex-GF mice were reduced to 65 and 92% of those in GF mice, respectively. Since both values are known to increase when the TCA cycle is blocked (Sugiura et al., [@B24]), the observed reductions in NADH and NADH/NAD^+^ ratio suggest normal intestinal microbiota induces active oxidative phosphorylation via the TCA cycle. From these findings, we suggest that, in the cerebrum, Ex-GF mice consume energy and accelerate energy production through glycolysis and TCA cycle more highly than GF mice. In other word, the cerebrum of Ex-GF mice is more active than that of GF mice.

Bacterial potential influence on cerebrum metabolic changes
-----------------------------------------------------------

Of 38 metabolites influenced by intestinal microbiota, 12 metabolites detected from the cerebrum but not cardiac plasma, are synthesized independently in the cerebrum and are influenced by MGB axis (Figure [5](#F5){ref-type="fig"}, metabolites shown in blue). Sixteen metabolites whose Ex-GF/GF ratio differed between the cerebrum and cardiac plasma are influenced by MGB axis and/or BBB (Figure [5](#F5){ref-type="fig"}, metabolites marked by \#). The fact that NANA is in this group is in conflict existing literature. In animal infant models, exogenous administration of NANA increased learning and memory performance as well as the concentration of NANA in the frontal cortex (Carlson and House, [@B3]; Wang et al., [@B26]). However, in the present study, NANA produced by intestinal microbiota was not transported to the blood. Therefore, it is doubtful whether dietary NANA influences the brain and behavior directly. We suppose that improvement of learning and memory performance by oral administration of NANA depends on the stimulation of intestinal microbiota, which is altered by supplements containing NANA through the MBG axis. Cerebral GABA concentration did not differ between GF mice and Ex-GF mice, although remarkable differences were observed in GABA cardiac plasma concentrations between GF mice and Ex-GF mice (Figure [8](#F8){ref-type="fig"}). This indicates that GABA is controlled by BBB and tightly regulated in the cerebrum. This questions the suitability of oral GABA supplementation studies to provide GABA to the brain.

![**Relative quantitative comparisons of GABA in colonic lumen content, cardiac plasma, and the cerebrum**. Data are represented as mean ± SD. \*\**p* \< 0.01.](fnsys-07-00009-g008){#F8}

Differences in RSD values between GF mice and Ex-GF mice (Figure [4](#F4){ref-type="fig"}) implies that individual differences in the metabolites found in the colonic content and cardiac plasma of Ex-GF mice is influenced by the diversity of intestinal microbiota (Matsumoto et al., [@B14]). Furthermore, these findings indicate that many metabolites produced by intestinal bacteria are filtrated and transported to brain via the blood through the BBB. However, six cerebral metabolites (Figure [5](#F5){ref-type="fig"}, metabolites shown in red) had similar Ex-GF/GF ratios between colonic luminal content, cardiac plasma, and the cerebrum. This may suggest that these metabolites may be transported from the colonic lumen to the cerebrum in the bloodstream without filtration by BBB. Further studies are required to fully understand how these metabolites are transported from the gut lumen to blood and from blood to the brain. Furthermore, the relationship between intestinal bacterial composition and brain metabolome is an area that clearly merits further study in the future.

These discussions center on a comparison between general knowledge and the data obtained in the present study. However, the neuronal effects of almost detected metabolites in the cerebrum are unclear. In future studies, researchers in various fields may find evidence that some of the newly identified metabolites are important for neuronal activities and diseases. Indeed, there is a possibility of detecting site-specific metabolome profiles when using CE-TOFMS. Further studies are required to analyze other parts of the brain.

In this study, many metabolites including neurotransmitters showed differences in the concentrations between GF mice and Ex-GF mice, indicating that normal intestinal microbiota closely connected with brain health and disease, development, attenuation, learning, memory, and behavior. We propose that through proper control of intestinal microbiota, cerebral nerve disorders may be prevented or alleviated in the future.
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###### 

**Anionic metabolites detected from cerebrum in GF mice and Ex-GF mice**.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ID       HMT DB^†^                                               Relative area^§^         Comparative analysis                                                                                                                                  
  -------- ------------------------------------------------------- ------------------------ --------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ------- ------- ------
  A_0052   2,3-Diphosphoglyceric acid                              C01159                   HMDB01294                         7.6E-05   6.7E-05   1.2E-04   1.5E-04   1.3E-04   2.0E-04   8.7E-05   2.7E-05   1.6E-04   4.0E-05   1.853   0.064   

  A_0007   2-Hydroxyisobutyric acid                                --                       HMDB00729                         1.3E-04   1.6E-04   1.8E-04   3.0E-04   2.2E-04   2.1E-04   1.6E-04   2.3E-05   2.4E-04   4.7E-05   1.525   0.073   

  A_0041   Phosphocreatine                                         C02305                   HMDB01511                         1.1E-04   1.1E-04   9.9E-05   1.8E-04   1.6E-04   1.1E-04   1.1E-04   7.2E-06   1.5E-04   3.5E-05   1.430   0.146   

  A_0015   5-Oxoproline                                            C01879                   HMDB00267                         1.9E-03   1.0E-03   5.4E-04   2.5E-03   1.6E-03   7.5E-04   1.1E-03   6.9E-04   1.6E-03   8.6E-04   1.398   0.517   

  A_0088   ADP-ribose                                              C00301                   HMDB01178                         2.2E-04   2.3E-04   3.8E-04   2.6E-04   3.8E-04   4.1E-04   2.7E-04   9.0E-05   3.5E-04   7.8E-05   1.272   0.338   

  A_0044   Ribose 5-phosphate                                      C00117                   HMDB01548                         1.1E-04   1.1E-04   1.1E-04   1.3E-04   1.4E-04   1.2E-04   1.1E-04   3.2E-06   1.3E-04   9.1E-06   1.190   0.044   \*

  A_0037   Isocitric acid                                          C00311                   HMDB00193                         1.1E-04   1.7E-04   1.2E-04   1.3E-04   1.5E-04   1.9E-04   1.3E-04   3.1E-05   1.6E-04   3.1E-05   1.189   0.377   

  A_0087   GTP                                                     C00044                   HMDB01273                         4.1E-04   3.9E-04   5.3E-04   6.2E-04   4.7E-04   4.6E-04   4.5E-04   7.9E-05   5.2E-04   9.0E-05   1.167   0.345   

  A_0067   NADPH_divalent                                          C00005                   HMDB00221                         5.4E-05   7.7E-05   7.4E-05   8.5E-05   6.9E-05   8.5E-05   6.8E-05   1.2E-05   8.0E-05   9.4E-06   1.166   0.281   

  A_0013   2-Hydroxyvaleric acid                                   --                       HMDB01863                         1.5E-04   1.7E-04   1.1E-04   1.9E-04   1.3E-04   1.9E-04   1.5E-04   2.8E-05   1.7E-04   3.3E-05   1.162   0.397   

  A_0036   Citric acid                                             C00158                   HMDB00094                         6.3E-03   7.2E-03   6.3E-03   9.3E-03   5.7E-03   7.8E-03   6.6E-03   5.3E-04   7.6E-03   1.8E-03   1.153   0.433   

  A_0032   Homovanillic acid                                       C05582                   HMDB00118                         9.4E-05   1.6E-04   1.6E-04   1.5E-04   1.6E-04   1.5E-04   1.4E-04   3.8E-05   1.5E-04   5.1E-06   1.109   0.568   

  A_0048   *myo*-Inositol 1-phosphate *myo*-Inositol 3-phosphate   C01177\                  HMDB00213\                        6.6E-04   6.0E-04   5.5E-04   7.3E-04   5.9E-04   6.7E-04   6.0E-04   5.8E-05   6.6E-04   6.7E-05   1.098   0.317   
                                                                   C04006                   HMDB06814                                                                                                                                             

  A_0025   Uric acid                                               C00366                   HMDB00289                         6.0E-05   7.8E-05   5.9E-05   6.3E-05   7.8E-05   6.9E-05   6.6E-05   1.1E-05   7.0E-05   7.9E-06   1.068   0.592   

  A_0074   Acetyl CoA_divalent                                     C00024                   HMDB01206                         5.5E-05   5.4E-05   4.6E-05   4.6E-05   5.6E-05   6.1E-05   5.2E-05   5.3E-06   5.4E-05   7.9E-06   1.048   0.677   

  A_0023   3-Hydroxy-3-methylglutaric acid                         C03761                   \-                                3.5E-04   3.1E-04   3.0E-04   3.6E-04   3.4E-04   3.1E-04   3.2E-04   2.3E-05   3.4E-04   2.4E-05   1.047   0.479   

  A_0077   GDP                                                     C00035                   HMDB01201                         1.5E-03   1.7E-03   2.1E-03   1.9E-03   1.6E-03   2.0E-03   1.8E-03   3.1E-04   1.8E-03   2.3E-04   1.033   0.803   

  A_0093   UDP-*N*-acetyl glucosamine                              C00043                   HMDB00290                         9.1E-04   1.0E-03   1.0E-03   1.1E-03   9.5E-04   9.9E-04   9.8E-04   6.5E-05   1.0E-03   8.3E-05   1.030   0.654   

  A_0056   *N*-Acetyl glucosamine 6-phosphate                      C00357                   HMDB01062                         1.2E-04   9.6E-05   8.0E-05   1.3E-04   9.3E-05   7.4E-05   9.7E-05   1.8E-05   1.0E-04   3.0E-05   1.025   0.909   

  A_0083   CDP-choline                                             C00307                   HMDB01413                         2.0E-04   1.8E-04   2.6E-04   2.2E-04   1.8E-04   2.4E-04   2.1E-04   4.0E-05   2.1E-04   3.1E-05   1.012   0.935   

  A_0002   Propionic acid                                          C00163                   HMDB00237                         1.7E-04   9.9E-05   1.1E-04   1.4E-04   1.3E-04   1.0E-04   1.3E-04   4.0E-05   1.3E-04   2.1E-05   1.010   0.964   

  A_0092   GDP-mannose GDP-galactose                               C00096\                  HMDB01163 -                       1.8E-04   2.2E-04   2.2E-04   2.1E-04   1.9E-04   2.4E-04   2.1E-04   2.3E-05   2.1E-04   2.4E-05   1.005   0.955   
                                                                   C02280                                                                                                                                                                         

  A_0017   Malic acid                                              C00149, C00497, C00711   HMDB00156, HMDB00744              1.5E-02   1.6E-02   1.5E-02   1.5E-02   1.3E-02   1.7E-02   1.5E-02   6.0E-04   1.5E-02   1.8E-03   1.001   0.992   

  A_0010   Fumaric acid                                            C00122                   HMDB00134                         1.9E-03   2.1E-03   1.9E-03   1.8E-03   1.7E-03   2.4E-03   2.0E-03   1.0E-04   2.0E-03   3.5E-04   0.997   0.977   

  A_0016   *N*-Acetyl-β-alanine                                    C01073                   --                                5.8E-05   7.2E-05   6.8E-05   6.8E-05   6.1E-05   6.6E-05   6.6E-05   7.3E-06   6.5E-05   3.7E-06   0.987   0.870   

  A_0091   ADP-glucose GDP-fucose                                  C00498\                  HMDB06557\                        8.2E-05   8.5E-05   8.9E-05   9.7E-05   7.9E-05   7.8E-05   8.6E-05   3.6E-06   8.5E-05   1.0E-05   0.987   0.873   
                                                                   C00325                   HMDB01095                                                                                                                                             

  A_0035   *N*-Acetyl glutamic acid                                C00624                   HMDB01138                         7.1E-04   6.6E-04   6.4E-04   6.9E-04   6.6E-04   6.1E-04   6.7E-04   3.6E-05   6.5E-04   4.1E-05   0.981   0.714   

  A_0029   *cis*-Aconitic acid                                     C00417                   HMDB00072                         1.6E-04   2.8E-04   1.5E-04   1.6E-04   1.9E-04   2.3E-04   2.0E-04   7.3E-05   1.9E-04   3.3E-05   0.974   0.920   

  A_0043   Ribulose 5-phosphate                                    C00199, C01101           HMDB00618                         2.5E-03   2.1E-03   1.7E-03   2.1E-03   2.3E-03   1.8E-03   2.1E-03   3.9E-04   2.1E-03   2.4E-04   0.969   0.817   

  A_0068   CoA_divalent                                            C00010                   HMDB01423                         4.1E-04   4.1E-04   4.4E-04   3.8E-04   3.8E-04   4.1E-04   4.2E-04   2.0E-05   3.9E-04   2.0E-05   0.927   0.138   

  A_0022   Pelargonic acid                                         C01601                   HMDB00847                         8.7E-05   5.5E-05   6.7E-05   5.3E-05   5.4E-05   8.7E-05   7.0E-05   1.6E-05   6.5E-05   1.9E-05   0.927   0.743   

  A_0006   Lactic acid                                             C00186, C00256, C01432   HMDB00190, HMDB01311              2.9E-01   2.8E-01   3.1E-01   2.7E-01   2.5E-01   3.0E-01   3.0E-01   1.3E-02   2.7E-01   2.7E-02   0.920   0.262   

  A_0094   CMP-*N*-acetylneuraminate                               C00128                   HMDB01176                         4.7E-04   5.7E-04   5.2E-04   4.9E-04   5.4E-04   3.9E-04   5.2E-04   4.9E-05   4.7E-04   7.7E-05   0.919   0.481   

  A_0031   Ascorbic acid                                           C00072                   HMDB00044                         3.5E-02   3.5E-02   3.2E-02   3.3E-02   2.8E-02   3.3E-02   3.4E-02   1.6E-03   3.1E-02   3.0E-03   0.918   0.255   

  A_0061   cAMP                                                    C00575                   HMDB00058                         2.7E-05   4.3E-05   3.5E-05   3.9E-05   2.3E-05   3.4E-05   3.5E-05   7.8E-06   3.2E-05   7.9E-06   0.916   0.667   

  A_0085   ATP                                                     C00002                   HMDB00538                         1.1E-03   1.1E-03   1.0E-03   1.1E-03   1.0E-03   7.9E-04   1.1E-03   3.4E-05   9.7E-04   1.7E-04   0.915   0.455   

  A_0070   FAD_divalent                                            C00016                   HMDB01248                         5.9E-05   7.3E-05   7.6E-05   6.5E-05   6.3E-05   5.7E-05   6.9E-05   9.2E-06   6.2E-05   4.0E-06   0.890   0.288   

  A_0090   UDP-glucuronic acid                                     C00167                   HMDB00935                         1.2E-04   1.4E-04   1.2E-04   1.1E-04   1.1E-04   1.2E-04   1.2E-04   1.3E-05   1.1E-04   4.9E-06   0.879   0.172   

  A_0051   Glucose 1-phosphate                                     C00103                   HMDB01586                         1.5E-04   2.0E-04   2.0E-04   1.8E-04   1.3E-04   1.7E-04   1.8E-04   2.9E-05   1.6E-04   2.3E-05   0.869   0.328   

  A_0018   Threonic acid                                           C01620                   HMDB00943                         1.2E-03   1.4E-03   1.3E-03   1.3E-03   1.0E-03   1.1E-03   1.3E-03   8.1E-05   1.1E-03   1.8E-04   0.860   0.211   

  A_0057   *N*-Acetylneuraminic acid                               C00270                   HMDB00230                         1.1E-03   1.0E-03   1.0E-03   9.2E-04   8.9E-04   8.1E-04   1.0E-03   4.3E-05   8.7E-04   5.6E-05   0.846   0.020   \*

  A_0014   Isethionic acid                                         C05123                   HMDB03903                         8.2E-04   9.5E-04   1.1E-03   7.7E-04   8.8E-04   7.6E-04   9.5E-04   1.3E-04   8.0E-04   6.6E-05   0.846   0.172   

  A_0089   UDP-glucose UDP-galactose                               C00029\                  HMDB00286\                        1.2E-03   1.5E-03   1.3E-03   1.0E-03   1.1E-03   1.3E-03   1.3E-03   1.3E-04   1.1E-03   1.1E-04   0.846   0.110   
                                                                   C00052                   HMDB00302                                                                                                                                             

  A_0030   *N*-Acetylaspartic acid                                 C01042                   HMDB00812                         2.0E-01   2.0E-01   2.2E-01   1.8E-01   1.6E-01   1.7E-01   2.1E-01   1.0E-02   1.7E-01   8.5E-03   0.838   0.014   \*

  A_0073   UDP                                                     C00015                   HMDB00295                         1.0E-04   1.2E-04   1.2E-04   1.1E-04   8.5E-05   9.2E-05   1.2E-04   1.1E-05   9.6E-05   1.4E-05   0.833   0.135   

  A_0009   3-Hydroxybutyric acid                                   C01089, C03197           HMDB00011, HMDB00357, HMDB00442   9.8E-04   1.2E-03   8.5E-04   7.7E-04   8.8E-04   8.4E-04   1.0E-03   1.6E-04   8.3E-04   5.6E-05   0.833   0.196   

  A_0054   Sedoheptulose 7-phosphate                               C05382                   HMDB01068                         9.5E-05   1.1E-04   1.2E-04   6.6E-05   1.0E-04   1.1E-04   1.1E-04   1.4E-05   9.1E-05   2.2E-05   0.831   0.298   

  A_0042   Pantothenic acid                                        C00864                   HMDB00210                         4.1E-04   4.5E-04   4.5E-04   3.2E-04   3.7E-04   3.8E-04   4.4E-04   2.1E-05   3.6E-04   3.2E-05   0.819   0.029   \*

  A_0038   Gluconic acid                                           C00257                   HMDB00625                         1.3E-04   1.1E-04   1.4E-04   1.1E-04   1.0E-04   9.8E-05   1.3E-04   1.3E-05   1.0E-04   6.6E-06   0.816   0.063   

  A_0040   Lauric acid                                             C02679                   HMDB00638                         1.5E-04   1.2E-04   1.5E-04   1.5E-04   1.1E-04   8.5E-05   1.4E-04   1.6E-05   1.1E-04   3.2E-05   0.816   0.308   

  A_0064   AMP                                                     C00020                   HMDB00045                         1.6E-02   2.1E-02   2.3E-02   1.7E-02   1.3E-02   1.9E-02   2.0E-02   3.7E-03   1.6E-02   3.3E-03   0.810   0.248   

  A_0046   Biotin                                                  C00120                   HMDB00030                         2.1E-04   2.4E-04   2.2E-04   1.7E-04   2.0E-04   1.6E-04   2.2E-04   1.7E-05   1.8E-04   1.8E-05   0.804   0.038   \*

  A_0055   *N*-Acetylglucosamine 1-phosphate                       C04256                   HMDB01367                         1.3E-04   1.2E-04   1.2E-04   1.2E-04   9.2E-05   9.0E-05   1.3E-04   6.0E-06   1.0E-04   1.9E-05   0.803   0.147   

  A_0050   *myo*-Inositol 2-phosphate                              --                       --                                7.5E-04   8.0E-04   9.6E-04   5.4E-04   6.3E-04   8.3E-04   8.4E-04   1.1E-04   6.7E-04   1.5E-04   0.799   0.191   

  A_0045   2-Deoxyglucose 6-phosphate                              C06369                   --                                8.4E-05   1.3E-04   6.9E-05   9.6E-05   5.2E-05   7.6E-05   9.4E-05   3.1E-05   7.4E-05   2.2E-05   0.793   0.434   

  A_0005   Butyric acid                                            C00246                   HMDB00039                         3.9E-05   5.5E-05   7.0E-05   4.6E-05   5.0E-05   3.4E-05   5.5E-05   1.5E-05   4.3E-05   8.2E-06   0.789   0.333   

  A_0059   CMP                                                     C00055                   HMDB00095                         2.1E-04   3.5E-04   3.3E-04   2.1E-04   1.7E-04   3.0E-04   3.0E-04   7.6E-05   2.3E-04   6.8E-05   0.757   0.286   

  A_0076   ADP                                                     C00008                   HMDB01341                         4.7E-03   5.7E-03   4.9E-03   3.8E-03   3.7E-03   4.0E-03   5.1E-03   5.4E-04   3.8E-03   1.3E-04   0.755   0.050   \*

  A_0078   Adenylosuccinic acid                                    C03794                   HMDB00536                         6.4E-04   8.0E-04   7.4E-04   4.6E-04   4.7E-04   7.1E-04   7.2E-04   8.1E-05   5.4E-04   1.4E-04   0.753   0.153   

  A_0019   Ethanolamine phosphate                                  C00346                   HMDB00224                         1.3E-02   1.6E-02   1.8E-02   1.2E-02   1.1E-02   1.2E-02   1.6E-02   2.3E-03   1.2E-02   3.9E-04   0.743   0.091   

  A_0066   GMP                                                     C00144                   HMDB01397                         2.5E-03   3.3E-03   3.3E-03   2.1E-03   2.0E-03   2.5E-03   3.0E-03   4.8E-04   2.2E-03   2.6E-04   0.730   0.079   

  A_0012   Succinic acid                                           C00042                   HMDB00254                         2.0E-02   2.1E-02   1.9E-02   1.5E-02   1.6E-02   1.3E-02   2.0E-02   1.3E-03   1.4E-02   1.7E-03   0.719   0.012   \*

  A_0021   3-Phenylpropionic acid                                  C05629                   HMDB00764                         1.3E-04   1.3E-04   1.1E-04   8.6E-05   8.0E-05   9.8E-05   1.2E-04   1.3E-05   8.8E-05   9.0E-06   0.715   0.023   \*

  A_0095   NAD^+^                                                  C00003                   HMDB00902                         1.3E-03   1.9E-03   1.7E-03   1.2E-03   9.6E-04   1.2E-03   1.6E-03   3.2E-04   1.1E-03   1.5E-04   0.702   0.107   

  A_0027   Dihydroxyacetone phosphate                              C00111                   HMDB01473                         1.9E-04   2.0E-04   2.2E-04   1.2E-04   1.7E-04   1.3E-04   2.0E-04   1.2E-05   1.4E-04   2.3E-05   0.694   0.024   \*

  A_0065   IMP                                                     C00130                   HMDB00175                         2.5E-03   2.8E-03   2.7E-03   2.1E-03   1.7E-03   1.7E-03   2.7E-03   1.7E-04   1.8E-03   2.6E-04   0.691   0.015   \*

  A_0008   2-Hydroxybutyric acid                                   C05984                   HMDB00008                         7.5E-05   8.4E-05   9.3E-05   5.1E-05   6.7E-05   5.6E-05   8.4E-05   8.9E-06   5.8E-05   8.3E-06   0.688   0.021   \*

  A_0097   NADP^+^                                                 C00006                   HMDB00217                         8.3E-05   9.0E-05   8.9E-05   7.0E-05   4.4E-05   5.7E-05   8.7E-05   3.8E-06   5.7E-05   1.3E-05   0.654   0.045   \*

  A_0096   NADH                                                    C00004                   HMDB01487                         1.9E-04   2.1E-04   2.3E-04   1.5E-04   1.5E-04   1.1E-04   2.1E-04   2.3E-05   1.3E-04   2.5E-05   0.646   0.020   \*

  A_0060   UMP                                                     C00105                   HMDB00288                         5.4E-04   1.1E-03   1.1E-03   5.4E-04   4.6E-04   7.5E-04   9.1E-04   3.3E-04   5.8E-04   1.5E-04   0.641   0.220   

  A_0034   3-Phosphoglyceric acid                                  C00197                   HMDB00807                         6.6E-04   5.3E-04   4.7E-04   3.3E-04   3.7E-04   3.3E-04   5.5E-04   9.5E-05   3.4E-04   2.3E-05   0.620   0.055   

  A_0028   Glycerol 3-phosphate                                    C00093                   HMDB00126                         4.0E-03   3.4E-03   3.9E-03   2.4E-03   3.5E-03   1.0E-03   3.8E-03   2.9E-04   2.3E-03   1.3E-03   0.612   0.178   

  A_0047   Glucose 6-phosphate                                     C00668, C01172, C00092   HMDB01401                         8.0E-05   1.0E-04   1.2E-04   5.8E-05   5.9E-05   6.4E-05   1.0E-04   2.0E-05   6.0E-05   2.9E-06   0.598   0.072   

  A_0049   Fructose 6-phosphate                                    C00085                   HMDB00124                         2.8E-05   1.8E-05   3.4E-05   1.7E-05   1.6E-05   1.3E-05   2.7E-05   7.9E-06   1.5E-05   2.0E-06   0.574   0.122   

  A_0062   Fructose 1,6-diphosphate                                C00354                   HMDB01058                         4.7E-04   4.4E-04   7.2E-04   2.7E-04   3.0E-04   2.2E-04   5.4E-04   1.5E-04   2.7E-04   4.1E-05   0.491   0.079   

  A_0086   Taurocholic acid                                        C05122                   HMDB00036                         1.2E-04   1.7E-04   1.6E-04   3.1E-05   1.4E-05   ND        1.5E-04   3.1E-05   2.3E-05   1.2E-05   0.150   0.010   \*\*
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^1^Ex-GF/GF ratio*.

*^2^Welch's *t*-test (\**p* \< 0.05, \*\**p* \< 0.01)*.

*ND, not detected*.

###### 

**Cationic metabolites detected from cerebrum in GF mice and Ex-GF mice**.

  ID       HMT DB^†^                              Relative area of standard   Comparative analysis                                                                                                                                  
  -------- -------------------------------------- --------------------------- --------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ------- ------- --------
  C_0003   Trimethylamine *N*-oxide               C01104                      HMDB00925                         2.2E-05   1.6E-05   1.8E-05   8.9E-05   9.3E-05   6.4E-05   1.9E-05   3.4E-06   8.2E-05   1.5E-05   4.390   0.015   \*
  C_0074   *N*^5^-Ethylglutamine                  C01047                      --                                6.8E-05   5.5E-05   5.9E-05   1.6E-04   1.2E-04   1.5E-04   6.1E-05   6.6E-06   1.4E-04   2.4E-05   2.361   0.022   \*
  C_0123   Cysteine glutathione disulfide         --                          HMDB00656                         6.3E-04   2.1E-04   9.6E-05   8.1E-04   1.0E-03   1.9E-04   3.1E-04   2.8E-04   6.8E-04   4.4E-04   2.173   0.299   
  C_0031   Cys                                    C00097, C00736, C00793      HMDB00574, HMDB03417              1.7E-03   5.6E-04   3.6E-04   2.6E-03   1.3E-03   7.3E-04   8.6E-04   7.1E-04   1.5E-03   9.5E-04   1.790   0.381   
  C_0029   2-Methylserine                         C02115                      --                                4.4E-05   5.1E-05   5.2E-05   1.0E-04   7.7E-05   8.3E-05   4.9E-05   4.2E-06   8.7E-05   1.2E-05   1.775   0.025   \*
  C_0073   3-Methylhistidine                      C01152                      HMDB00479                         5.4E-04   6.6E-04   6.5E-04   1.2E-03   9.5E-04   9.5E-04   6.1E-04   6.7E-05   1.0E-03   1.3E-04   1.677   0.018   \*
  C_0099   Cystine                                C00491, C01420              HMDB00192                         2.0E-05   ND        ND        2.9E-05   3.7E-05   ND        2.0E-05   NA        3.3E-05   5.5E-06   1.673   NA      
  C_0018   Hypotaurine                            C00519                      HMDB00965                         6.5E-04   4.2E-04   4.9E-04   9.5E-04   6.9E-04   7.4E-04   5.2E-04   1.2E-04   7.9E-04   1.4E-04   1.524   0.059   
  C_0089   Trp                                    C00078, C00525, C00806      HMDB00929                         1.0E-03   9.8E-04   9.4E-04   1.3E-03   1.5E-03   1.5E-03   9.7E-04   2.7E-05   1.4E-03   1.1E-04   1.480   0.015   \*
  C_0035   Pipecolic acid                         C00408                      HMDB00070, HMDB00716, HMDB05960   1.6E-04   1.6E-04   1.6E-04   2.2E-04   2.5E-04   2.3E-04   1.6E-04   7.4E-07   2.3E-04   1.3E-05   1.444   0.010   \*
  C_0044   Thiaproline                            --                          --                                1.0E-03   5.9E-04   2.8E-04   1.1E-03   9.6E-04   5.4E-04   6.2E-04   3.6E-04   8.7E-04   3.0E-04   1.405   0.410   
  C_0032   Nicotinamide                           C00153                      HMDB01406                         7.3E-03   4.6E-03   5.5E-03   7.7E-03   8.9E-03   7.6E-03   5.8E-03   1.4E-03   8.0E-03   7.4E-04   1.385   0.093   
  C_0109   Inosine                                C00294                      HMDB00195                         1.5E-02   8.3E-03   6.6E-03   1.6E-02   1.7E-02   8.4E-03   1.0E-02   4.5E-03   1.4E-02   4.7E-03   1.378   0.371   
  C_0079   Tyr                                    C00082, C01536, C06420      HMDB00158                         3.3E-03   3.3E-03   3.8E-03   4.3E-03   5.0E-03   4.9E-03   3.5E-03   3.2E-04   4.8E-03   3.8E-04   1.371   0.012   \*
  C_0060   *Threo*-β-Methyl aspartic acid         C03618                      \-                                9.4E-05   6.7E-05   6.6E-05   9.5E-05   1.1E-04   1.0E-04   7.6E-05   1.6E-05   1.0E-04   6.5E-06   1.339   0.091   
  C_0072   Phe                                    C00079, C02057, C02265      HMDB00159                         3.6E-03   3.9E-03   3.7E-03   4.9E-03   5.1E-03   4.9E-03   3.7E-03   1.4E-04   5.0E-03   1.4E-04   1.330   0.000   \*\*\*
  C_0053   1-Methyl-4-imidazoleacetic acid        C05828                      HMDB02820                         9.5E-05   7.5E-05   1.0E-04   1.1E-04   1.5E-04   9.5E-05   9.1E-05   1.5E-05   1.2E-04   2.8E-05   1.319   0.209   
  C_0047   Hypoxanthine                           C00262                      HMDB00157                         8.9E-03   5.6E-03   4.2E-03   9.7E-03   9.4E-03   5.0E-03   6.2E-03   2.4E-03   8.0E-03   2.6E-03   1.292   0.431   
  C_0065   Guanine                                C00242                      HMDB00132                         2.1E-05   2.1E-05   1.9E-05   2.2E-05   3.1E-05   2.3E-05   2.0E-05   1.4E-06   2.6E-05   5.0E-06   1.263   0.202   
  C_0045   Asp                                    C00049, C00402, C16433      HMDB00191, HMDB06483              2.7E-03   2.7E-03   2.7E-03   3.6E-03   3.4E-03   3.4E-03   2.7E-03   2.8E-05   3.4E-03   1.2E-04   1.259   0.007   \*\*
  C_0112   Guanosine                              C00387                      HMDB00133                         1.8E-03   1.1E-03   1.0E-03   1.8E-03   1.9E-03   1.2E-03   1.3E-03   4.1E-04   1.6E-03   3.9E-04   1.233   0.405   
  C_0086   SDMA                                   --                          HMDB03334                         2.4E-05   2.4E-05   2.0E-05   2.8E-05   3.1E-05   2.4E-05   2.3E-05   2.2E-06   2.8E-05   3.7E-06   1.215   0.139   
  C_0058   Spermidine                             C00315                      HMDB01257                         9.9E-04   9.4E-04   1.1E-03   1.0E-03   1.5E-03   1.2E-03   1.0E-03   1.0E-04   1.2E-03   2.6E-04   1.200   0.308   
  C_0116   Arg-Glu                                --                          --                                8.2E-06   7.6E-06   8.3E-06   8.3E-06   9.5E-06   1.1E-05   8.0E-06   3.5E-07   9.6E-06   1.3E-06   1.194   0.167   
  C_0061   Gln                                    C00064, C00303, C00819      HMDB00641, HMDB03423              7.0E-03   7.0E-03   7.3E-03   8.2E-03   8.2E-03   9.0E-03   7.1E-03   1.7E-04   8.5E-03   4.6E-04   1.188   0.025   \*
  C_0008   1-Methyl-2-pyrrolidone                 C11118                      --                                1.2E-04   9.6E-05   1.0E-04   1.2E-04   1.1E-04   1.4E-04   1.1E-04   1.1E-05   1.2E-04   1.5E-05   1.170   0.171   
  C_0019   Cytosine                               C00380                      HMDB00630                         4.1E-06   3.1E-06   3.3E-06   4.2E-06   4.1E-06   3.9E-06   3.5E-06   5.4E-07   4.1E-06   1.8E-07   1.152   0.220   
  C_0013   2-Aminoisobutyric acid                 C03665                      HMDB01906                         9.8E-05   1.2E-04   9.4E-05   1.3E-04   1.1E-04   1.2E-04   1.0E-04   1.3E-05   1.2E-04   7.3E-06   1.141   0.177   
  C_0094   Carnosine                              C00386                      HMDB00033                         2.4E-03   2.4E-03   2.3E-03   3.0E-03   2.9E-03   2.2E-03   2.4E-03   7.3E-05   2.7E-03   4.6E-04   1.140   0.340   
  C_0021   Uracil                                 C00106                      HMDB00300                         3.3E-04   2.9E-04   2.6E-04   3.8E-04   3.6E-04   2.6E-04   2.9E-04   3.9E-05   3.3E-04   6.0E-05   1.139   0.392   
  C_0093   Cystathionine                          C00542, C02291              HMDB00099                         6.6E-04   4.4E-04   6.6E-04   5.7E-04   8.3E-04   6.0E-04   5.9E-04   1.2E-04   6.7E-04   1.4E-04   1.137   0.497   
  C_0067   His                                    C00135, C00768, C06419      HMDB00177                         5.5E-03   5.9E-03   5.4E-03   6.1E-03   6.1E-03   6.8E-03   5.6E-03   2.5E-04   6.3E-03   4.3E-04   1.135   0.071   
  C_0100   Homocarnosine                          C00884                      HMDB00745                         5.1E-03   4.7E-03   5.5E-03   5.4E-03   6.4E-03   5.6E-03   5.1E-03   4.3E-04   5.8E-03   5.4E-04   1.130   0.173   
  C_0014   Choline                                C00114                      HMDB00097                         2.3E-02   2.0E-02   1.4E-02   2.7E-02   2.3E-02   1.4E-02   1.9E-02   4.6E-03   2.1E-02   6.3E-03   1.118   0.643   
  C_0020   Histamine                              C00388                      HMDB00870                         2.5E-05   2.5E-05   3.0E-05   2.3E-05   4.1E-05   2.6E-05   2.7E-05   3.2E-06   3.0E-05   9.3E-06   1.116   0.630   
  C_0046   Adenine                                C00147                      HMDB00034                         3.6E-04   2.9E-04   2.5E-04   3.2E-04   3.9E-04   2.9E-04   3.0E-04   5.4E-05   3.3E-04   5.1E-05   1.114   0.470   
  C_0122   *S*-Adenosyl methionine                C00019                      HMDB01185                         4.9E-04   4.4E-04   5.2E-04   5.2E-04   5.5E-04   5.4E-04   4.8E-04   4.1E-05   5.4E-04   1.8E-05   1.114   0.134   
  C_0030   Betaine aldehyde + H~2~O               C00576                      HMDB01252                         1.7E-05   1.4E-05   1.2E-05   1.9E-05   1.5E-05   1.3E-05   1.5E-05   2.6E-06   1.6E-05   3.0E-06   1.108   0.532   
  C_0034   1-Methylhistamine                      C05127                      HMDB00898                         7.1E-05   4.2E-05   6.7E-05   5.6E-05   7.7E-05   6.6E-05   6.0E-05   1.6E-05   6.6E-05   1.1E-05   1.104   0.610   
  C_0114   Argininosuccinic acid                  C03406                      HMDB00052                         2.0E-04   1.9E-04   1.8E-04   1.9E-04   2.1E-04   2.2E-04   1.9E-04   9.3E-06   2.1E-04   1.7E-05   1.099   0.191   
  C_0078   Serotonin                              C00780                      HMDB00259                         4.4E-05   4.4E-05   4.4E-05   3.6E-05   6.4E-05   4.5E-05   4.4E-05   3.1E-07   4.8E-05   1.4E-05   1.099   0.649   
  C_0103   Uridine                                C00299                      HMDB00296                         1.5E-03   1.2E-03   1.2E-03   1.4E-03   1.6E-03   1.3E-03   1.3E-03   1.8E-04   1.4E-03   1.8E-04   1.096   0.443   
  C_0087   Spermine                               C00750                      HMDB01256                         7.6E-05   9.7E-05   7.7E-05   8.6E-05   7.9E-05   1.1E-04   8.3E-05   1.2E-05   9.1E-05   1.4E-05   1.091   0.524   
  C_0002   Gly                                    C00037                      HMDB00123                         2.1E-02   1.7E-02   1.6E-02   1.9E-02   2.4E-02   1.7E-02   1.8E-02   2.3E-03   2.0E-02   3.7E-03   1.090   0.563   
  C_0076   Arg                                    C00062, C00792              HMDB00517, HMDB03416              8.6E-03   6.7E-03   8.8E-03   8.3E-03   9.4E-03   8.5E-03   8.0E-03   1.2E-03   8.7E-03   6.2E-04   1.087   0.429   
  C_0023   Pro                                    C00148, C00763, C16435      HMDB00162, HMDB03411              6.6E-03   6.2E-03   6.3E-03   7.5E-03   6.7E-03   6.4E-03   6.4E-03   2.3E-04   6.9E-03   5.8E-04   1.076   0.280   
  C_0063   Met                                    C00073, C00855, C01733      HMDB00696                         1.9E-03   1.7E-03   2.2E-03   2.1E-03   2.0E-03   2.1E-03   1.9E-03   2.2E-04   2.1E-03   4.5E-05   1.075   0.375   
  C_0113   His-Glu                                --                          --                                3.9E-06   3.0E-06   N.D.      3.7E-06   3.5E-06   4.0E-06   3.5E-06   6.4E-07   3.7E-06   2.8E-07   1.068   0.695   
  C_0071   Methionine sulfoxide                   C02989                      HMDB02005                         2.5E-04   1.8E-04   2.7E-04   2.1E-04   2.9E-04   2.5E-04   2.3E-04   4.7E-05   2.5E-04   4.2E-05   1.067   0.691   
  C_0108   Adenosine                              C00212                      HMDB00050                         2.3E-02   2.2E-02   2.3E-02   2.5E-02   2.3E-02   2.4E-02   2.2E-02   9.2E-04   2.4E-02   5.6E-04   1.062   0.102   
  C_0005   β-Ala                                  C00099                      HMDB00056                         2.2E-03   1.9E-03   2.1E-03   1.8E-03   2.6E-03   2.1E-03   2.1E-03   1.8E-04   2.2E-03   3.9E-04   1.062   0.650   
  C_0105   γ-Glu-Cys                              C00669                      HMDB01049                         1.3E-04   1.1E-04   1.3E-04   1.6E-04   1.2E-04   1.2E-04   1.2E-04   1.5E-05   1.3E-04   2.1E-05   1.060   0.650   
  C_0110   Saccharopine                           C00449                      HMDB00279                         3.8E-04   3.5E-04   3.7E-04   2.9E-04   4.9E-04   3.7E-04   3.7E-04   1.7E-05   3.9E-04   1.0E-04   1.058   0.754   
  C_0082   *N*^6^-Acetyllysine                    C02727                      HMDB00206                         2.8E-05   2.3E-05   3.0E-05   2.9E-05   3.0E-05   2.7E-05   2.7E-05   3.9E-06   2.9E-05   1.8E-06   1.053   0.605   
  C_0015   GABA                                   C00334                      HMDB00112                         5.7E-03   4.6E-03   4.9E-03   4.4E-03   6.2E-03   5.3E-03   5.1E-03   5.9E-04   5.3E-03   9.1E-04   1.048   0.722   
  C_0068   2-Aminoadipic acid                     C00956                      HMDB00510                         1.5E-03   1.9E-03   2.0E-03   1.8E-03   1.7E-03   2.2E-03   1.8E-03   2.7E-04   1.9E-03   2.9E-04   1.048   0.726   
  C_0040   Asn                                    C00152, C01905, C16438      HMDB00168                         3.4E-03   3.5E-03   3.7E-03   3.8E-03   3.6E-03   3.6E-03   3.5E-03   1.7E-04   3.7E-03   1.3E-04   1.046   0.275   
  C_0097   Thr-Asp                                --                          --                                1.2E-05   1.4E-05   1.1E-05   1.1E-05   1.4E-05   1.4E-05   1.2E-05   1.5E-06   1.3E-05   2.0E-06   1.045   0.721   
  C_0075   *N*-Acetylornithine                    C00437                      HMDB03357                         1.3E-05   8.3E-06   ND        1.1E-05   ND        ND        1.1E-05   3.5E-06   1.1E-05   NA        1.043   NA      
  C_0025   Betaine                                C00719                      HMDB00043                         9.6E-04   8.3E-04   9.5E-04   9.2E-04   1.1E-03   8.3E-04   9.1E-04   7.0E-05   9.5E-04   1.4E-04   1.042   0.696   
  C_0010   Homoserine lactone                     --                          --                                7.8E-05   6.8E-05   8.0E-05   7.3E-05   7.7E-05   8.4E-05   7.5E-05   6.9E-06   7.8E-05   5.6E-06   1.032   0.660   
  C_0107   Thiamine                               C00378                      HMDB00235                         6.8E-05   6.0E-05   5.3E-05   6.7E-05   6.2E-05   5.8E-05   6.0E-05   7.7E-06   6.2E-05   4.7E-06   1.029   0.753   
  C_0111   1-Methyladenosine                      C02494                      HMDB03331                         9.6E-05   1.1E-04   1.5E-04   1.2E-04   1.2E-04   1.2E-04   1.2E-04   2.6E-05   1.2E-04   3.8E-06   1.028   0.850   
  C_0064   Triethanolamine                        C06771                      --                                1.1E-05   1.2E-05   1.4E-05   1.5E-05   1.2E-05   1.2E-05   1.2E-05   1.5E-06   1.3E-05   1.6E-06   1.028   0.799   
  C_0026   Val                                    C00183, C06417, C16436      HMDB00883                         8.5E-03   7.5E-03   7.5E-03   7.8E-03   8.2E-03   8.0E-03   7.8E-03   5.5E-04   8.0E-03   1.9E-04   1.022   0.653   
  C_0056   Acetylcholine                          C01996                      HMDB00895                         4.5E-04   5.0E-04   6.0E-04   4.8E-04   4.9E-04   6.1E-04   5.2E-04   7.8E-05   5.3E-04   7.3E-05   1.021   0.869   
  C_0115   5′-Deoxy-5′-methyl thioadenosine       C00170                      HMDB01173                         1.9E-05   1.6E-05   1.7E-05   2.1E-05   1.6E-05   1.6E-05   1.8E-05   1.3E-06   1.8E-05   2.9E-06   1.016   0.891   
  C_0054   Stachydrine                            C10172                      HMDB04827                         1.3E-04   9.7E-05   1.4E-04   1.5E-04   1.3E-04   8.6E-05   1.2E-04   2.2E-05   1.2E-04   3.4E-05   1.014   0.946   
  C_0085   Gly-Asp                                \-                          \-                                8.2E-05   9.0E-05   8.5E-05   1.0E-04   8.4E-05   7.3E-05   8.6E-05   4.3E-06   8.6E-05   1.4E-05   1.009   0.935   
  C_0039   Leu                                    C00123, C01570, C16439      HMDB00687                         9.5E-03   8.3E-03   8.4E-03   8.9E-03   9.0E-03   8.4E-03   8.7E-03   7.0E-04   8.8E-03   3.1E-04   1.004   0.941   
  C_0080   Phosphorylcholine                      C00588                      HMDB01565                         1.6E-02   1.6E-02   1.8E-02   1.6E-02   1.6E-02   1.6E-02   1.6E-02   1.1E-03   1.6E-02   2.3E-04   0.994   0.891   
  C_0036   *trans*-Glutaconic acid                C02214                      HMDB00620                         9.0E-05   9.7E-05   9.9E-05   7.7E-05   1.1E-04   9.7E-05   9.5E-05   4.7E-06   9.4E-05   1.7E-05   0.992   0.945   
  C_0090   Carboxymethyl lysine                   --                          --                                5.5E-05   5.2E-05   5.2E-05   5.1E-05   5.7E-05   5.0E-05   5.3E-05   2.1E-06   5.2E-05   3.7E-06   0.989   0.818   
  C_0095   2′-Deoxycytidine                       C00881                      HMDB00014                         3.3E-05   2.2E-05   2.6E-05   3.5E-05   2.7E-05   1.9E-05   2.7E-05   5.6E-06   2.7E-05   7.8E-06   0.988   0.955   
  C_0038   Ile                                    C00407, C06418, C16434      HMDB00172                         4.8E-03   4.2E-03   4.1E-03   4.4E-03   4.3E-03   4.3E-03   4.4E-03   4.1E-04   4.3E-03   6.2E-05   0.987   0.841   
  C_0012   2-Aminobutyric acid                    C02261, C02356              HMDB00452                         1.7E-04   1.4E-04   1.7E-04   1.7E-04   1.5E-04   1.6E-04   1.6E-04   2.0E-05   1.6E-04   7.1E-06   0.987   0.879   
  C_0062   Glu                                    C00025, C00217, C00302      HMDB00148, HMDB03339              1.4E-02   1.4E-02   1.5E-02   1.4E-02   1.3E-02   1.5E-02   1.4E-02   4.6E-04   1.4E-02   6.3E-04   0.987   0.698   
  C_0022   Creatinine                             C00791                      HMDB00562                         6.6E-04   5.9E-04   6.5E-04   5.6E-04   6.3E-04   6.7E-04   6.3E-04   4.0E-05   6.2E-04   5.5E-05   0.978   0.745   
  C_0083   Gly-Leu                                C02155                      HMDB00759                         1.5E-04   1.4E-04   1.5E-04   1.6E-04   1.4E-04   1.3E-04   1.5E-04   9.7E-06   1.4E-04   1.4E-05   0.978   0.759   
  C_0059   Lys                                    C00047, C00739, C16440      HMDB00182, HMDB03405              1.1E-02   9.5E-03   1.0E-02   9.8E-03   1.1E-02   1.0E-02   1.0E-02   8.8E-04   1.0E-02   4.4E-04   0.977   0.702   
  C_0084   *N*^6^,*N*^6^,*N*^6^-Trimethyllysine   C03793                      HMDB01325                         3.4E-04   4.3E-04   4.1E-04   4.0E-04   3.3E-04   4.2E-04   3.9E-04   4.7E-05   3.8E-04   4.7E-05   0.977   0.823   
  C_0104   Pyridoxamine 5′-phosphate              C00647                      HMDB01555                         3.4E-04   3.5E-04   3.7E-04   3.2E-04   3.7E-04   3.5E-04   3.5E-04   1.4E-05   3.5E-04   2.4E-05   0.976   0.641   
  C_0117   Glutathione (GSSG)\_divalent           C00127                      HMDB03337                         1.8E-02   2.0E-02   1.7E-02   1.7E-02   2.1E-02   1.6E-02   1.9E-02   1.4E-03   1.8E-02   2.7E-03   0.973   0.794   
  C_0092   *N*-Acetylglucosamine                  C00140                      HMDB00215                         1.5E-04   1.6E-04   1.4E-04   1.6E-04   1.5E-04   1.3E-04   1.5E-04   6.8E-06   1.5E-04   1.3E-05   0.971   0.639   
  C_0069   Carnitine                              C00318, C00487, C15025      HMDB00062                         8.6E-03   7.7E-03   7.9E-03   7.4E-03   9.0E-03   7.1E-03   8.1E-03   4.9E-04   7.8E-03   1.0E-03   0.969   0.736   
  C_0001   Urea                                   C00086                      HMDB00294                         7.5E-02   7.4E-02   7.7E-02   7.0E-02   7.3E-02   7.5E-02   7.5E-02   1.6E-03   7.3E-02   2.7E-03   0.968   0.274   
  C_0042   Creatine                               C00300                      HMDB00064                         2.2E-02   2.2E-02   2.3E-02   2.1E-02   2.1E-02   2.2E-02   2.2E-02   4.4E-04   2.1E-02   3.2E-04   0.965   0.078   
  C_0051   Tyramine                               C00483                      HMDB00306                         1.2E-05   1.0E-05   2.0E-05   1.1E-05   1.5E-05   1.3E-05   1.4E-05   5.0E-06   1.3E-05   2.0E-06   0.962   0.878   
  C_0007   Ala                                    C00041, C00133, C01401      HMDB00161, HMDB01310              1.1E-03   1.2E-03   1.2E-03   1.3E-03   9.6E-04   1.2E-03   1.2E-03   4.3E-05   1.1E-03   1.6E-04   0.960   0.667   
  C_0077   Citrulline                             C00327                      HMDB00904                         1.1E-03   1.0E-03   1.1E-03   1.2E-03   8.2E-04   1.1E-03   1.1E-03   6.9E-05   1.0E-03   1.9E-04   0.959   0.735   
  C_0004   Putrescine                             C00134                      HMDB01414                         1.2E-04   9.7E-05   1.0E-04   9.5E-05   1.0E-04   1.0E-04   1.1E-04   1.2E-05   1.0E-04   4.7E-06   0.951   0.544   
  C_0106   Glycero phosphocholine                 C00670                      HMDB00086                         1.8E-02   1.9E-02   2.1E-02   1.3E-02   2.1E-02   2.0E-02   1.9E-02   1.5E-03   1.8E-02   4.2E-03   0.947   0.725   
  C_0027   Homoserine                             C00263                      HMDB00719                         2.3E-04   2.6E-04   2.7E-04   2.6E-04   2.2E-04   2.4E-04   2.5E-04   2.0E-05   2.4E-04   1.8E-05   0.940   0.379   
  C_0055   4-Guanidinobutyric acid                C01035                      HMDB03464                         3.3E-04   2.6E-04   3.3E-04   3.0E-04   3.0E-04   2.5E-04   3.1E-04   4.4E-05   2.8E-04   3.3E-05   0.929   0.534   
  C_0119   Thiamine phosphate                     C01081                      HMDB02666                         5.2E-05   4.8E-05   4.1E-05   4.3E-05   4.8E-05   3.9E-05   4.7E-05   5.6E-06   4.4E-05   4.4E-06   0.924   0.436   
  C_0043   Ornithine                              C00077, C00515, C01602      HMDB00214, HMDB03374              3.4E-04   2.7E-04   4.3E-04   3.5E-04   2.8E-04   3.2E-04   3.5E-04   7.7E-05   3.2E-04   3.5E-05   0.917   0.597   
  C_0102   Cytidine                               C00475                      HMDB00089                         2.0E-03   1.8E-03   1.6E-03   2.1E-03   1.4E-03   1.4E-03   1.8E-03   2.2E-04   1.6E-03   4.1E-04   0.891   0.520   
  C_0033   Taurine                                C00245                      HMDB00251                         2.8E-02   3.0E-02   3.2E-02   2.8E-02   2.4E-02   2.7E-02   3.0E-02   1.8E-03   2.7E-02   2.5E-03   0.885   0.128   
  C_0028   Thr                                    C00188, C00820              HMDB00167                         1.8E-02   1.8E-02   1.9E-02   1.4E-02   1.6E-02   1.7E-02   1.8E-02   4.3E-04   1.6E-02   1.3E-03   0.884   0.101   
  C_0118   Glutathione (GSH)                      C00051                      HMDB00125                         5.6E-03   6.1E-03   7.3E-03   5.5E-03   4.2E-03   6.7E-03   6.3E-03   8.6E-04   5.5E-03   1.2E-03   0.874   0.422   
  C_0121   *S*-Adenosylhomo cysteine              C00021                      HMDB00939                         6.8E-05   7.6E-05   7.7E-05   6.7E-05   6.7E-05   5.9E-05   7.4E-05   5.0E-06   6.4E-05   4.8E-06   0.874   0.080   
  C_0091   β-Ala-Lys                              C05341                      --                                3.4E-05   2.4E-05   3.8E-05   2.4E-05   3.6E-05   2.4E-05   3.2E-05   7.1E-06   2.8E-05   7.0E-06   0.873   0.521   
  C_0024   Guanidoacetic acid                     C00581                      HMDB00128                         4.6E-04   3.8E-04   4.2E-04   4.0E-04   3.4E-04   3.3E-04   4.2E-04   4.1E-05   3.6E-04   3.8E-05   0.855   0.131   
  C_0057   γ-Butyrobetaine                        C01181                      HMDB01161                         1.8E-03   1.7E-03   1.8E-03   1.6E-03   1.3E-03   1.5E-03   1.8E-03   3.1E-05   1.5E-03   1.3E-04   0.841   0.059   
  C_0017   *N*-Methylaniline                      C02299                      --                                ND        1.6E-05   1.5E-05   1.1E-05   1.4E-05   ND        1.5E-05   9.7E-07   1.3E-05   2.2E-06   0.834   0.325   
  C_0070   5-Hydroxylysine                        C16741                      HMDB00450                         1.4E-05   1.0E-05   1.2E-05   1.1E-05   7.4E-06   1.1E-05   1.2E-05   1.8E-06   1.0E-05   2.3E-06   0.831   0.295   
  C_0096   γ-Glu-2-aminobutyric acid              --                          --                                1.7E-04   1.6E-04   2.0E-04   1.5E-04   1.6E-04   1.3E-04   1.8E-04   1.9E-05   1.5E-04   1.3E-05   0.829   0.090   
  C_0088   *O*-Acetylcarnitine                    C02571                      HMDB00201                         5.0E-04   2.9E-04   4.6E-04   3.8E-04   3.3E-04   3.1E-04   4.2E-04   1.1E-04   3.4E-04   3.4E-05   0.816   0.370   
  C_0041   Gly-Gly                                C02037                      HMDB11733                         1.2E-04   1.4E-04   1.5E-04   1.1E-04   1.0E-04   1.2E-04   1.4E-04   1.3E-05   1.1E-04   1.1E-05   0.804   0.053   
  C_0101   5,6,7,8-Tetrahydrobiopterin            C00272                      HMDB00027                         N.D.      1.3E-05   1.5E-05   7.9E-06   1.2E-05   1.4E-05   1.4E-05   1.6E-06   1.1E-05   3.1E-06   0.794   0.264   
  C_0016   Ser                                    C00065, C00716, C00740      HMDB00187, HMDB03406              9.8E-04   1.1E-03   1.1E-03   8.2E-04   7.3E-04   8.3E-04   1.0E-03   6.5E-05   7.9E-04   5.5E-05   0.759   0.007   \*\*
  C_0081   *N*^8^-Acetylspermidine                C01029                      HMDB02189                         5.6E-05   4.6E-05   4.6E-05   3.9E-05   3.5E-05   3.6E-05   4.9E-05   6.0E-06   3.7E-05   2.0E-06   0.746   0.056   
  C_0050   Trigonelline                           C01004                      HMDB00875                         1.4E-04   9.8E-05   1.2E-04   1.0E-04   8.2E-05   7.4E-05   1.2E-04   1.8E-05   8.7E-05   1.6E-05   0.738   0.095   
  C_0048   1-Methylnicotinamide                   C02918                      HMDB00699                         4.5E-05   5.3E-05   5.4E-05   4.3E-05   3.4E-05   3.4E-05   5.0E-05   5.2E-06   3.7E-05   5.0E-06   0.736   0.033   \*
  C_0098   Ser-Glu                                --                          --                                5.0E-05   4.1E-05   5.0E-05   3.5E-05   3.8E-05   2.9E-05   4.7E-05   5.5E-06   3.4E-05   4.8E-06   0.729   0.040   \*
  C_0052   Urocanic acid                          C00785                      HMDB00301                         1.0E-04   3.6E-05   4.4E-05   4.1E-05   6.9E-05   1.2E-05   6.0E-05   3.5E-05   4.1E-05   2.8E-05   0.677   0.503   
  C_0037   Hydroxyproline                         C01015, C01157              HMDB06055, HMDB00725              1.6E-03   1.7E-03   1.6E-03   1.2E-03   9.9E-04   1.0E-03   1.6E-03   3.2E-05   1.1E-03   1.1E-04   0.651   0.009   \*\*
  C_0009   Cyclohexylamine                        C00571                      --                                1.5E-05   1.9E-05   2.3E-05   1.4E-05   8.5E-06   1.4E-05   1.9E-05   4.1E-06   1.2E-05   3.4E-06   0.647   0.094   
  C_0120   *S*-Lactoylglutathione                 C03451                      HMDB01066                         ND        ND        1.8E-05   ND        ND        1.0E-05   1.8E-05   NA        1.0E-05   NA        0.584   NA      
  C_0066   Dopamine                               C03758                      HMDB00073                         2.9E-04   5.8E-04   7.1E-04   2.4E-04   2.7E-04   3.5E-04   5.3E-04   2.2E-04   2.9E-04   5.6E-05   0.543   0.188   

*^1^Ex-GF/GF ratio*.

*^2^Welch's *t*-test (\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, NA, not available)*.

*ND, not detected*.

Abbreviations
=============

BBB, blood-brain barrier; CE-TOFMS, capillary electrophoresis with time-of-flight mass spectrometry; CNS, central nervous system; DA, dopamine; Ex-GF, ex-germ-free; GF, germ-free; MGB axis, microbiota-gut-brain axis; RSD, relative standard deviations.
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